MRI in Breast Cancer: Assessment of Response to Neoadjuvant Therapy
Are you using magnetic resonance imaging (MRI) in your practice to assess treatment response to neoadjuvant therapy? If not, maybe you should.
Physician and Nurse Credit: | Available at Medscape Education |
RT Credit: | 1.00 ARRT Category A |
Target Audience and Goal Statement
This activity is intended for radiologists, radiologic technologists, oncologists, pathologists, obstetricians & gynecologists, radiation oncologists, surgeons (including surgical oncologists), primary care physicians (PCPs), internal medicine specialists, nurses/nurse practitioners (NPs), and physician assistants (PAs) involved in the care of patients with or at risk of breast cancer.
The goal of this activity is for the learner to be better able to use imaging to accurately assess treatment response to neoadjuvant therapy and effectively collaborate to provide patients with the best possible options for treatment of their early breast cancer.
LEARNING OBJECTIVES
Upon completion of this activity, participants will:
TOPICS
The Oncology Perspective: Assessment of Response to Neoadjuvant Therapy
Joyce A. O’Shaughnessy, MD
The Radiology Perspective: Assessment of Response to Neoadjuvant Therapy
Elizabeth A. Morris, MD
Panel: The Radiology and Oncology Multidisciplinary Team: Improving Patient Care
Joyce A. O’Shaughnessy, MD and Elizabeth A. Morris, MD
Radiologic Technologist Continuing Education
This program has been approved by the American Society of Radiologic Technologists (ASRT) for 1.0 hour of ARRT Category A continuing education credit.
How to Receive Credit
Important note: For Physician credit you must enroll and participate on the Medscape Education website.
Joyce Ann O'Shaughnessy, MD
Celebrating Women Chair in Breast Cancer Research
Baylor University Medical Center
Director, Breast Cancer Research Program
Texas Oncology
US Oncology Research Network
Dallas, Texas
Questions?
For questions regarding this program, please contact ICPME:
Email: information@icpmed.com
PROVIDED BY